What SQN Clinical does

SQN Clinical, now operating as Veristat, is a full-service Contract Research Organization (CRO) providing integrated clinical development services to pharmaceutical and biotechnology sponsors. The firm's service portfolio spans the full clinical development lifecycle, including strategic consulting, clinical operations, regulatory affairs, biometrics, pharmacovigilance, medical affairs, regulatory writing, quality assurance, and resourcing/functional service provision. Its therapeutic coverage spans oncology/hematology, neurology/psychiatry, endocrine/metabolic, inflammation/immunology, infectious disease, and cardiovascular disease, with specialized solution verticals in biologics (cell and gene therapies, vaccines), rare diseases including pediatric populations, decentralized trials, trial rescue programs, and natural history studies. Differentiated capabilities include adaptive trial design consulting, rescue of stalled clinical programs, and decentralized trial execution enabling remote patient participation.

The company's underlying operational technology centers on clinical trial data management, biostatistics, statistical programming, and standards implementation for regulatory-grade submissions. The offering is positioned as an integrated platform where therapeutic expertise intersects with functional service lines, allowing sponsors to engage the firm as a single accountable partner across planning, execution, and regulatory submission. The core technical differentiators are integration/interoperability across the clinical development workflow and accuracy/precision in biometrics and regulatory publishing. No proprietary AI/ML systems, software products, or platform technology are disclosed; the business is fundamentally a professional services organization executing human-expert-led clinical research workflows.

Commercially, Veristat operates as a private B2B enterprise with direct sales engagement targeting pharmaceutical and biotech sponsors through a formal RFP intake process. Pricing is quote-based via the RFP system, with multi-year service contracts typical of full-service CRO engagements. Revenue is generated through professional services contracts for clinical trial execution and regulatory support, with no subscription, transactional, or marketplace revenue streams disclosed. The company maintains a digital marketing presence via website content (library, blog, webinars, podcasts, case studies, newsletters) and corporate social channels (LinkedIn, Twitter/X, YouTube, Facebook). No named customer logos, revenue figures, funding history, or ownership structure are disclosed in available sources, and the company appears to be founder/management-owned with no parent company or institutional investor signals present.

Name

SQN Clinical

Legal name

Veristat, LLC

Website

https://synequanon.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

51–100 employees

Short description

SQN Clinical (Veristat) is a full-service Contract Research Organization providing integrated clinical development, regulatory affairs, biometrics, and pharmacovigilance services to pharmaceutical and biotechnology sponsors across multiple therapeutic areas.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

Keywords

• Clinical research services
• Contract research organization
• Clinical trial management
• Regulatory affairs services
• Biometrics and biostatistics

Headquarters

HQ city

Diss

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Research Services: Full-service CRO providing integrated clinical development services including strategic consulting, clinical operations, regulatory affairs, biometrics, pharmacovigilance, and medical affairs. Revenue is generated through service contracts with pharmaceutical and biotechnology companies conducting clinical trials.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

SQN Clinical (now operating as Veristat) is a full-service Contract Research Organization (CRO) that provides integrated clinical development services to pharmaceutical and biotechnology sponsors. The company delivers strategic consulting, clinical operations, regulatory affairs, biometrics, pharmacovigilance, medical affairs, and regulatory writing across therapeutic areas including oncology, neurology, rare diseases, infectious disease, and cardiovascular disease, with specialized solutions for biologics, cell and gene therapies, vaccines, decentralized trials, and rescue trials.

Product overview

SQN Clinical has rebranded to Veristat, a full-service CRO offering integrated clinical development services. The company provides a comprehensive portfolio organized into therapeutic areas (Oncology/Hematology, Neurology/Psychiatry, Endocrine/Metabolic, Inflammation/Immunology, Infectious Disease, Cardiovascular Disease), solution specializations (Biologics including Cell and Gene Therapies and Vaccines, Rare Diseases with Pediatric focus, Decentralized Trials, Rescue Trials, Natural History Trials), and core service lines (Strategic Consulting, Regulatory Affairs, Clinical Operations, Medical Affairs, Biometrics, Pharmacovigilance, Regulatory Writing, Quality Assurance & Compliance, and Resourcing/FSP). The offering functions as a unified full-service CRO platform where therapeutic expertise intersects with specialized solutions and integrated service delivery.

Differentiator

Problem solved

Functional benefit

Products and services

• Full-Service Solutions

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators2 records

Recent moves4 records

Expansion highlights5 records

Broad incumbents

• IQVIA: Largest global full-service CRO with end-to-end clinical development, biometrics, regulatory, and real-world evidence capabilities; competes with Veristat for enterprise sponsor RFPs and represents the upper-bound scale benchmark in the same CRO category.
• ICON plc: Global full-service CRO (including post-PRA merger) offering clinical operations, biometrics, regulatory, and laboratory services across all major therapeutic areas; competes across the same RFP pool as Veristat at greater scale.
• Parexel International: Large global CRO with deep regulatory, biometrics, and clinical operations capabilities including specialty in oncology, rare disease, and cell/gene therapy — direct overlap with Veristat's most differentiated segments at greater scale.
• Labcorp Drug Development (formerly Covance): Global CRO and central laboratory services provider embedded in a diagnostics platform; competes with Veristat across clinical operations, biometrics, and central lab work at a very different scale and breadth.
• Charles River Laboratories: Provides CRO services (Research Models & Services, Discovery & Safety, Manufacturing Solutions) including clinical support; broader preclinical-to-clinical offering that overlaps Veristat's clinical and safety/pharmacovigilance lines.

Direct peers

• Medpace: Mid-to-large full-service CRO with strong therapeutic specialization (oncology, rare disease, cardiometabolic) and integrated biometrics — closest comparable in business model, sponsor mix, and growth profile to a specialized mid-sized CRO like Veristat.
• Syneos Health: Full-service biopharmaceutical solutions organization combining clinical CRO services with commercial capabilities; directly comparable in offering breadth and pharma/biotech sponsor orientation.
• Worldwide Clinical Trials: Mid-sized full-service CRO with therapeutic specialization in neuroscience, oncology, and rare diseases — directly comparable mid-market peer competing for similar specialty sponsor mandates.
• Premier Research: Specialty CRO focused on biotech and mid-sized pharma with particular depth in rare disease, oncology, and pediatric trials — directly competes with Veristat in the niche segment it most emphasizes.
• CTI Clinical Trial & Consulting Services: Mid-sized specialty CRO with therapeutic depth in hematology/oncology, rare diseases, and cell/gene therapy — closely comparable mid-market peer competing for the same specialty sponsor mandates.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/Sqnclinical
• YouTubeyoutube.com/@veristat
• Facebookfacebook.com/SQN-Clinical-113900880328437
• LinkedInlinkedin.com/company/veristat-llc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SQN Clinical